Mansoor A. Khan, PhD, RPh

Dean, Irma Lerma Rangel College of Pharmacy Regents and Distinguished University Professor of Pharmaceutical Sciences Presidential Impact Fellow Irma Lerma Rangel College of Pharmacy
Contact
  • 979.436.0561
  • Texas A&M Irma Lerma Rangel School of Pharmacy, Mail Stop 1114 159 Reynolds Medical Building
    College Station, TX 77843
  • Fax: 979.436.0087

Education

  • PhD in Pharmaceutics (focus on industrial pharmacy and biopharmaceutics) St John's University, College of Pharmacy and Allied Health Professions, New York, 1992
  • Masters of Science in Pharmaceutics (focus on physical pharmacy and drug delivery systems) Idaho State University, 1988
  • Master of Science in Pharmaceutical Technology Andhra University, India, 1984
  • Bachelor of Science in Pharmacy Kakatiya University, India, 1982

Research Interests

  • Formulations design and development
  • Biopharmaceutics
  • 3D printing (led the FDA New Drug Review Team that approved the first 3d-printed product on August 3, 2015)

Awards & Honors

  • American Association of Pharmaceutical Scientists (AAPS) elected chair of pharmaceutics and drug delivery (PDD)
  • American Association of Pharmaceutical Scientists (AAPS) founding chair of formulations design and development (FDD)
  • Editorial board of Pharmaceutical Technology, International Journal of Pharmaceutics, AAPSPharmsciTech, and the Drug Delivery and Translational Research
  • FDA representative to European Medical Agency, EMA (pediatric working group, and pediatric formulations committee), WHO (generic quality and pediatric guidelines committee), USP (expert panel on dosage forms), FIP (program chair and keynote speaker), DOD/DARPA (continuous manufacturing advisory panel), Clinton HIV/AID panel (dosage forms expert), NIH (scientific advisory board of nanotech characterization lab, several study sections and PI in the FDA:NIH IAG), and NASA (PI of the recent FDA:NASA Research Cooperative Agreement)
  • American Association of Pharmaceutical Scientists (AAPS) and American Association of Indian Pharmaceutical Scientists (AAiPS) Fellow
  • FDA/CDER 2015 outstanding ANDA reviews award
  • More than ten FDA/CDER Team Excellence Awards, Scientific Achievement Awards, and Exemplary Performance Awards
  • Outstanding alumni award from St. Johns University, College of Pharmacy
  • Excellence Award from Texas A&M University Health Science Center
  • 2012 AAPS Research Achievement Award in Formulations Design and Development

Certifications & Training

  • Professional Licensure Registered Pharmacist NY State Lic. # 44017 - Active

Publications

2012 Withdrawal of generic budeprion for nonbioequivalence
Woodcock, J., Khan, M., & Yu, L. X. (2012). Withdrawal of generic budeprion for nonbioequivalence. New England Journal of Medicine, 367(26), 2463-2465.
2016 A new chapter in pharmaceutical manufacturing: 3D printed drug products
Norman J, Madurawe RD, Moore CM, Khan MA, and Khairuzzaman A., A new chapter in pharmaceutical manufacturing: 3D printed drug products, Adv Drug Del Rev, 2016, S0169-409X(16)30077-1.
2016 Risk-based In Vitro Performance Assessment of Extended Release Abuse Deterrent Formulations
Xu, X., Gupta, A., Al-Ghabeish, M., Calderon, S., and Khan, M*., Risk-based In Vitro Performance Assessment of Extended Release Abuse Deterrent Formulations, Int. J. Pharm., 2016. 16, 500 (1-2), 255-67.
2015 Biopharmaceutical Drug Product Development and Quality by Design
Hershenson S, Martin-Moe S, Khan MA, Jameel F (Editors), Biopharmaceutical Drug Product Development and Quality by Design, ISBN 978-1-4939-2316-8, New York: Springer, 2015, AAPS Press.